Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor
Authors
Keywords
-
Journal
CLINICAL PHARMACOKINETICS
Volume 60, Issue 5, Pages 569-583
Publisher
Springer Science and Business Media LLC
Online
2021-03-30
DOI
10.1007/s40262-021-00984-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
- (2020) Hussin A. Rothan et al. JOURNAL OF AUTOIMMUNITY
- The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
- (2020) Calvin J Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inclusion of Adolescents With Adults in Phase 3 Clinical Trials: Overview of the Current State and a Call for Action
- (2020) Mohamed‐Eslam F. Mohamed et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
- (2020) Emmie de Wit et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
- (2020) Calvin J. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
- (2020) Jason D. Goldman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?
- (2020) Mekonnen Sisay Frontiers in Pharmacology
- Management of acute kidney injury in patients with COVID-19
- (2020) Claudio Ronco et al. Lancet Respiratory Medicine
- Coronavirus disease 2019 (COVID-19): A literature review
- (2020) Harapan Harapan et al. Journal of Infection and Public Health
- Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis
- (2020) Ren Mao et al. Lancet Gastroenterology & Hepatology
- Liver injury in COVID-19: management and challenges
- (2020) Chao Zhang et al. Lancet Gastroenterology & Hepatology
- Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy Subjects
- (2020) Rita Humeniuk et al. CTS-Clinical and Translational Science
- COVID-19 and Liver
- (2020) Dinesh Jothimani et al. JOURNAL OF HEPATOLOGY
- Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
- (2020) Brandi N. Williamson et al. NATURE
- Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
- (2020) Leora R. Feldstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19: A promising cure for the global panic
- (2020) Balachandar Vellingiri et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action
- (2020) Egor P Tchesnokov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan
- (2020) Hu Zhang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment
- (2018) Erik Mogalian et al. CLINICAL PHARMACOKINETICS
- Scientific white paper on concentration-QTc modeling
- (2017) Christine Garnett et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
- (2017) Timothy P. Sheahan et al. Science Translational Medicine
- GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo- and Paramyxoviruses
- (2017) Michael K. Lo et al. Scientific Reports
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
- (2016) Travis K. Warren et al. NATURE
- Impact of Ignoring Extraction Ratio When Predicting Drug-Drug Interactions, Fraction Metabolized, and Intestinal First-Pass Contribution
- (2010) B. J. Kirby et al. DRUG METABOLISM AND DISPOSITION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started